Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Halychpharm is a prominent Ukrainian pharmaceutical company based in Lviv and a founding member of the Arterium Corporation. Established in 1911, the company has a long-standing history of specializing in the production of herbal-based medicines, galenic preparations, and finished dosage forms including tablets and injectables. Halychpharm operates modern, GMP-certified manufacturing facilities and is recognized for its expertise in phytochemical extraction and the development of original medicines such as Thiotriazoline and Urolesan. The company serves a broad range of therapeutic areas, including cardiology, neurology, and urology, supplying essential healthcare products to markets across Eastern Europe and Central Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Halychpharm.